{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:42:13Z","timestamp":1784612533371,"version":"3.55.0"},"reference-count":61,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2020,5,3]]},"DOI":"10.1080\/00498254.2019.1669844","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:42:06Z","timestamp":1568792526000},"page":"606-613","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule"],"prefix":"10.1080","volume":"50","author":[{"given":"Xiao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-5530","authenticated-orcid":false,"given":"Dong-Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children\u2019s Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-023X","authenticated-orcid":false,"given":"Zhi-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children\u2019s Hospital of Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094708"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000134"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/11535950-000000000-00000"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31829f1ab8"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140010-00002"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1220-z"},{"key":"e_1_3_2_8_1","first-page":"333","article-title":"Recent insights into the pathogenesis of nephrotic syndrome","volume":"104","author":"Certikova-Chabova V","year":"2013","unstructured":"Certikova-Chabova V, Tesar V. (2013). Recent insights into the pathogenesis of nephrotic syndrome. Minerva Med 104:333\u201347.","journal-title":"Minerva Med"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-1066-y"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.11.033"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14184-0"},{"key":"e_1_3_2_12_1","first-page":"1374","article-title":"FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation","volume":"27","author":"Fay JW","year":"1995","unstructured":"Fay JW, Nash RA, Wingard JR, et\u00a0al. (1995). FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. Transplant Proc 27:1374.","journal-title":"Transplant Proc"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.8.3514.bloodjournal8783514"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.06.008"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140010-00005"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.238"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm688"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1501-0"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12176"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0116"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13605"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200403000-00002"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00168-1"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12174"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90153-1"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12276"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.57.7.544"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2005.04.005"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1370-3"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2310-x"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100021"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/11594760-000000000-00000"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2012.4"},{"key":"e_1_3_2_34_1","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash RA","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C, et\u00a0al. (2000). Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96:2062\u20138.","journal-title":"Blood"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3634.bloodjournal8893634"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13154"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.11.4383.4383"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1305"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.01.025"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1471-8"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00288.x"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu297"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0380-0"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V85769"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700813"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12396"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31823415cc"},{"key":"e_1_3_2_49_1","first-page":"2305","article-title":"Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus","volume":"17","author":"Wang D","year":"2019","unstructured":"Wang D, Chen X, Li Z. (2019a). Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus. Exp Ther Med 17:2305\u20139.","journal-title":"Exp Ther Med"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1601791."},{"key":"e_1_3_2_51_1","first-page":"4023","article-title":"Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models","volume":"17","author":"Wang D","year":"2019","unstructured":"Wang D, Lu J, Li Q, Li Z. (2019c). Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models. Exp Ther Med 17:4023\u201331.","journal-title":"Exp Ther Med"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1631505."},{"key":"e_1_3_2_53_1","first-page":"6436","article-title":"Efficacy and safety of tacrolimus in treating pediatric refractory nephrotic syndrome: a meta-analysis","volume":"11","author":"Wang DD","year":"2018","unstructured":"Wang DD, Chen X, Li ZP. (2018a). Efficacy and safety of tacrolimus in treating pediatric refractory nephrotic syndrome: a meta-analysis. Int J Clin Exp Med 11:6436\u201344.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12707"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.050302"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1075-7"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02922.x"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-015-0062-y"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP202189"},{"key":"e_1_3_2_60_1","first-page":"1108","article-title":"Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations","volume":"27","author":"Yasuhara M","year":"1995","unstructured":"Yasuhara M, Hashida T, Toraguchi M, et\u00a0al. (1995). Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. Transplant Proc 27:1108\u201310.","journal-title":"Transplant Proc"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.210"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32835fcbb6"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2019.1669844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:14:48Z","timestamp":1772748888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2019.1669844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,3]]}},"alternative-id":["10.1080\/00498254.2019.1669844"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2019.1669844","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"value":"0049-8254","type":"print"},{"value":"1366-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}